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Abstract
The immune system is a real-time example of an evolving system that
navigates the essentially infinite complexity of protein sequence space. How
this system responds to disease and vaccination is discussed. Of particular
focus is the case when vaccination leads to increased susceptibility to disease,
a phenomenon termed original antigenic sin. A physical theory of protein
evolution to explain limitations in the immune system response to vaccination
and disease is discussed, and original antigenic sin is explained as stemming
from localization of the immune system response in antibody sequence space.
This localization is a result of the roughness in sequence space of the evolved
antibody affinity constant for antigen and is observed for diseases with high
year-to-year mutation rates, such as influenza.
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1 Introduction
Our immune system protects us against death by infection (Perelson and Weisbuch, 1997).
A major component of the immune system is generation of antibodies, pro-
tein molecules that bind specific antigens. To recognize invading pathogens,
the immune system performs a search of the amino acid sequence space of
possible antibodies. To find useful antibodies in the effectively infinite protein
sequence space, the immune system has evolved a hierarchical strategy. The
first step involves creating the DNA sequences for B cells that code for mod-
erately effective antibodies through rearrangement of immune-system-specific
gene fragments from the genome (Tonegawa, 1983; Ehlich and Kuppers, 1995).
This process is called VDJ recombination. This combinatorial process can
produce on the order of 1014 different antibodies through recombination of
pieces of antibodies. The second step, which occurs when a specific anti-
gen invades our body, is somatic hypermutation. Somatic hypermutation
is the process of mutation that occurs when the B cells that produce the
antibodies divide and multiply. Only those B cells that produce antibodies
that bind the antigen with higher affinity are propagated by this mutation
and selection process, and another name for this process is affinity matu-
ration. Somatic hypermutation is essentially a search of the amino acid se-
quence space at the level of individual point mutations (Griffiths et al., 1984;
Neuberger and Milstein, 1995; Tomlinson et al., 1996).
Binding of an antibody to an antigen results, when the immune system
is protective, in clearance of the pathogen from which the antigen derives.
Typical binding constants between antibodies and antigens are on the order
of 104 to 106 or 107 l/mol (Janeway et al., 2001), although values as large as
1011 l/mol or greater can be produced in experiments (Midelfort et al., 1999).
Binding of antibody to antigen can prevent progression of disease by three
mechanisms. If many antibodies bind and cover an invading pathogen, then
the pathogen is prevented from entering cells and so fails to cause infection.
Binding of antibodies to a pathogen may also cause phagocytic cells to ingest
the pathogen. Finally, binding of antibodies to a pathogen may activate
other components of the immune system, such as the complement, which
contains pathogen-destroying proteins that punch holes in the membrane of
the pathogen.
The space of possible antibodies is extremely large. Considering just the
variable part of the heavy chain, there are on the order of 20100 ≈ 10130
possibilities. The immune system has evolved a hierarchical strategy for
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searching this vast space of possible antibodies (Janeway et al., 2001). The
hierarchy is composed of two steps. The first step is VDJ recombination,
in which the three pieces of the variable region are joined together. Given
the many possibilities for each of these three regions encoded within the
genome of an individual, there are on the order of 1012 possibilities of these
random antibodies, or naive sequences. Of these, only on the order of 108 are
expressed in a human individual at one point in time. Not all of these naive
sequences lead to useful antibodies. Those antibodies that bind proteins
of the self would cause autoimmune disease, and the B cells that produce
them are killed. The B cells that produce antibodies that do not bind any
proteins are left to die. But the B cells that produce antibodies that bind
antigen multiply and divide. As the B cells divide, the DNA that codes
for the antibodies mutates at a high rate. The process, termed somatic
hypermutation, can be viewed as a local optimization of the initial, naive
guesses.
The consequence of an immune system response to antigen is the estab-
lishment of a state of memory (Gray, 1993). Immunological memory is the
ability of the immune system to respond more rapidly and effectively to anti-
gens that have been encountered previously. Specific memory is maintained
in the DNA of long-lived memory B cells that can persist without residual
antigen (Black and Rosen, 1962; Sprent, 1993).
The adaptive vertebrate immune system is a wonder of modern evolu-
tion. Under most circumstances, the dynamics of the immune system is
well-matched to the dynamics of pathogen growth during a typical infection.
Some pathogens, however, have evolved escape mechanisms that interact in
subtle ways with the immune system dynamics. In addition, negative interac-
tions between the immune system, which has evolved over 400 000 000 years,
and vaccination, which has been practiced for only 200 years, are possible.
Although our immune system is highly effective, some limitations have
been reported. The phenomenon known as “original antigenic sin” is the ten-
dency for antibodies produced in response to exposure to influenza virus anti-
gens to suppress the creation of new, different antibodies in response to expo-
sure to different versions of the flu (Fazekas de St. Groth and Webster, 1966a;
Fazekas de St. Groth and Webster, 1966b). Roughly speaking, the immune
system responds only to the antigen fragments, or epitopes, that are in com-
mon with the original flu virus. As a result, individuals vaccinated against
the flu may become more susceptible to infection by mutated strains of the
flu than would individuals receiving no vaccination.
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The phenomenon of original antigenic sin has since been observed in
dengue fever, human immunodeficiency virus (HIV), and other viruses. Dengue
fever is caused by four distinct viral strains (Rigau-Perez et al., 1998). Once
the immune system has memorized a response to one type of dengue, sec-
ondary infection with a different type of dengue places patients at the largest
risk for dengue hemorrhagic fever (Halstead et al., 1983; Halstead, 1989; Vaughn et al., 2000).
Thus, vaccination with one type of dengue virus can actually increase the
rate of dengue hemorrhagic fever due to suppression of an immune response
to the three other types of dengue virus. Similarly, the rapid replication of
HIV, coupled with a high mutation rate, leads to the generation of many
variants of HIV, even within a single infected patient (Condra et al., 1995;
Finzi and Silliciano, 1998; Nara et al., 1990). HIV is initially controlled by
cytotoxic T lymphocytes (CTLs), but may subsequently escape control through
mutation of the relevant T-cell epitope, since CTLs also preferentially re-
spond against the initial rather than mutated epitope (Good et al., 1993;
Klenerman and Zinkernagel, 1998). Original antigenic sin of the CTL re-
sponse impedes clearance of new HIV variants and enhances the chance that
the immune system will be unable to control the HIV infection. The details
of how original antigenic sin works, even at a qualitative level, are unknown.
Another early example of a limitation in the immune response came from
the observation by Hoskins et al. that repeated annual influenza vaccina-
tion gave worse protection than did single vaccination among English school
boys (Hoskins et al., 1979). Later studies, such as that by Keitel et al. ob-
served that repeated vaccination is more effective than is single vaccination
(Keitel et al., 1997).
While the Hoskins and Keitel experiments seem inconsistent, this is not
necessarily the case. It may be that these experiments were performed un-
der different conditions. In other words, there may be an additional order
parameter that one needs to consider in order to understand these two ex-
periments. This is indeed the case. The crucial order parameter is the num-
ber of accumulated mutations in the influenza virus, or “antigenic distance”
(Smith et al., 1999). As parameterized by the antigenic distance, repeated
vaccination was found to have higher efficacy than the single vaccination
when the distance between the vaccine and the influenza was small, whereas
repeated vaccination was found to be less effective when the distance between
the vaccine and the influenza was large. Hoskins’ and Keitel’s are, thus, not
necessarily inconsistent. It is not known, however, why the efficacy of single
and repeated vaccination should vary as was observed in the experiments.
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In this article, I offer an explanation for the reported limitations in the im-
mune system response using a model of protein evolution (Deem and Lee, 2003).
The dynamics of affinity maturation is described by a search in antibody se-
quence space for increased binding constants between antibody and antigen.
It is shown that an immune system response to an antigen generates localized
memory B cell sequences. This set of localized sequences reduces the ability
of the immune system to respond to subsequent exposures to different but
related antigens. It is this competitive process between memory sequences
and the VDJ recombinations of secondary exposure that is responsible for
the reported limitations in the immune system.
2 The Random Energy Model
A random energy model is used to represent the interaction between the
antibodies and the influenza proteins. This model captures the essence of the
correlated ruggedness of the interaction energy in the variable space, the vari-
ables being the antibody amino acid sequences and the identity of the disease
proteins, and the correlations being mainly due to the physical structure of
the antibodies. The random energy model allows study of the sequence-level
dynamics of the immune/antigen system, which would otherwise be an in-
tractable problem at the atomic scale, with 104 atoms per antibody, 108 anti-
bodies per individual, 6×109 individuals, and many possible influenza strains.
Use of random energy theory to treat correlations in otherwise intractable
physical systems goes back at least to Bohr’s random matrix theory for nu-
clear cross sections (Bohr, 1936) and has been used for quantum chaos, dis-
ordered mesoscopic systems, QCD, and quantum gravity (Guhr et al., 1998).
Close to the present application is the study of spin glasses by random energy
models (Sherrington and Kirkpatrick, 1975; Derrida, 1980), protein folding
by coarse-grained models (Bryngelson and Wolynes, 1987; Gutin and Shakhnovich, 1993),
and evolutionary systems by NK-type models (Bogarad and Deem, 1999;
Derrida and Peliti, 1991; Weisbuch, 1990; Drossel, 2001).
In detail, the generalized NK model used considers three different kinds
of interactions within an antibody: interaction within a subdomain (U sd),
interactions between subdomains (U sd−sd), and direct binding interaction
between antibody and antigen (U c). In the context of protein evolution,
parameters of the model have been calibrated (Bogarad and Deem, 1999;
Kauffman and Levin, 1987; Perelson and Macken, 1995). The energy func-
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tion of a protein is given by
U =
M∑
i=1
U sdαi +
M∑
i>j=1
U sd−sdij +
P∑
i=1
U ci , (1)
whereM is the number of antibody secondary structural subdomains, and P
is the number of antibody amino acids contributing directly to the binding.
The subdomain energy U sd is
U sdαi =
1√
M(N −K + 1)
N−K+1∑
j=1
σαi(aj , aj+1, · · ·, aj+K−1), (2)
where N is the number of amino acids in a subdomain, and K is the range of
local interaction within a subdomain. All subdomains belong to one of L = 5
different types (e.g., helices, strands, loops, turns, and others). The quenched
Gaussian random number σαi is different for each value of its argument for a
given subdomain type, αi. All of the Gaussian σ values have zero mean and
unit variance. The energy of interaction between secondary structures is
U sd−sdij =
√
2
DM(M − 1)
D∑
k=1
σkij(a
i
j1
, · · ·, aijK/2; a
j
jK/2+1
, · · ·, ajjK) .
(3)
The number of interactions between secondary structures is set to D = 6.
Here σkij and the interacting amino acids, j1, · · ·, jK , are selected at random
for each interaction (k, i, j). The chemical binding energy of each antibody
amino acid to the antigen is given by
U ci =
1√
P
σi(ai) . (4)
The contributing amino acid, i, and the unit-normal weight of the binding,
σi, are chosen at random. Using experimental results, P = 5 amino acids are
taken to contribute directly to the binding event. Here only five chemically
distinct amino acid classes (e.g., negative, positive, polar, hydrophobic, and
other) are considered since each different type of amino acid behaves as a
completely different chemical entity within the random energy model.
The generalized NK model, while a simplified description of real proteins,
captures much of the thermodynamics of protein folding and ligand binding.
6
In the model, a specific B cell repertoire is represented by a specific set of
amino acid sequences. Moreover, a specific instance of the random param-
eters within the model represents a specific antigen. An immune response
that finds a B cell that produces an antibody with high affinity constant to
a specific antigen corresponds in the model to finding a sequence having a
low energy for a specific parameter set.
The random character of the generalized NK model makes the energy
rugged in antibody sequence space. The energy is, moreover, correlated
by the local antibody structure (K = 4), the secondary antibody structure
(U sd−sd), and the interaction with the influenza proteins (U c). As the immune
system explores the space of possible antibodies, localization is possible if the
correlated ruggedness of the interaction energy is sufficiently great.
3 Parameters of the Immune System
Since the variable region in each light and heavy chain of an antibody is
about 100 amino acids long, and most of the binding typically occurs in one
of the two chains, a single sequence length of 100 is chosen (Edelman, 1970;
Porter, 1973). The value M = 10 is chosen since there are roughly 10 sec-
ondary structures in a typical antibody and thus choose N = 10. The im-
mune system contains of the order of 108 B cells divided into different speci-
ficities (107 for the mouse) (Klinman and Press, 1975), and the frequency of
a specific B cell participating in the initial immune response is roughly 1 in
105 (Janeway et al., 2001). Hence, 103 sequences are used during an immune
response.
The hierarchical strategy of the immune system is used to search the
antibody sequence space for high affinity antibodies. Initial combination of
optimized subdomains is followed by a point mutation and selection pro-
cedure (Bogarad and Deem, 1999). To mimic combinatorial joining of gene
segments during B cell development, a naive B cell repertoire is produced by
choosing each subdomain sequence from pools that have Npool amino acid
segments obtained by minimizing the appropriate U sd. To fit the theoretical
heavy-chain diversity of 3× 1011 (Janeway et al., 2001), Npool = 3 sequences
are chosen from among the top 300 sequences for each subdomain type.
Somatic hypermutation occurs at the rate of roughly one mutation per
variable regions of light and heavy chains per cell division, which occurs every
6 to 8 hours during intense cell proliferation (French et al., 1989; Kocks and Rajewsky, 1989).
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Hence, in the simulation, 0.5 point mutations are done per sequence, the best
(highest affinity) x = 20% sequences are kept, and then these are amplified
back up to a total of 103 copies in one round, which corresponds to 1/3 day.
That is, the probability of picking one of the, possibly mutated, sequences
for the next round is
pselect =
{
1/200, U ≤ U200
0, U > U200
, (5)
where U200 is the 200th best energy of the 10
3 sequences after the mutation
events, and this equation is employed 103 times to select randomly the 103
sequences for the next round. Given a specific antigen, i.e. a specific set of
interaction parameters, 30 rounds (10 days) of point mutation and selection
are performed in one immune response. In this way, memory B cells for the
antigen are generated.
The affinity constant is given as a function of energy,
Keq = exp(a− bU) , (6)
where a and b are determined by the dynamics of the mutation and se-
lection process. Affinity constants resulting from VDJ recombination are
roughly 104, affinity constants after the first response of affinity maturation
are roughly 106, and affinity constants after a second response of affinity
maturation are roughly 107 l/mol (Janeway et al., 2001) These values fix the
selection strength, x = 20%. By comparison to the dynamics of the model,
the values a = −18.56 and b = 1.67 are obtained.
The memory B cells, key to immunological memory, give rapid and effec-
tive response to the same antigen due to their increased affinity for previously-
encountered antigens. The focus is on the role of the memory cells in the
immune response to different antigens. The “distance” between a first antigen
and the second antigen is given by the probability, p, of changing parame-
ters of interaction within subdomain (U sd), subdomain-subdomain (U sd−sd),
and chemical binding (U c) terms. Within U sd, only the subdomain type, αi,
is changed, not the parameters σα, which are probably fixed by structural
biology and should be independent of the antigen. This means that in the
model, the primary response is always from the same set of theoretically pos-
sible naive antibodies, analogous to the primary response of one individual
with a fixed set of naive possibilities from his or her genome.
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4 Immune System Dynamics
The number of memory and naive B cells that participate in the immune
response to the second antigen is estimated by the ratio of the respective
affinity constants. From the definition of the affinity constant,
Keq =
[Antigen : Antibody]
[Antigen] [Antibody]
, (7)
the binding probability is proportional to the affinity constant and to the
concentration of antigen-specific antibody, which is 102 times greater for the
memory sequences (Janeway et al., 2001). The 102 times great concentration
of memory antibodies is significant, because it biases the immune response
toward the memory. The average affinity for the second antigen of the 103
memory cells, Keqm , and that of the 10
3 B cells from the naive repertoire of
optimized subdomain sequences, Keqn , are measured. The ratio 10
2Keqm /K
eq
n
gives the ratio of memory cells to naive cells. For exposure to the second
antigen, 30 rounds (10 days) of point mutation and selection are performed,
starting with 105Keqm /(10
2Keqm + K
eq
n ) memory cells and 10
3Keqn /(10
2Keqm +
Keqn ) naive cells, since both memory and naive sequences participate in the
secondary response (Berek and Milstein, 1987).
Before going in to more details of the immune system response, I mention
two possibilities for suboptimal dynamics. The first is localization in anti-
body amino-acid sequence space. Imagine the binding energy of an antibody
for this year’s flu as a function of antibody sequence. There will be a region
where the best antibodies are located. The binding energy of antibodies for
next year’s flu will be slightly different, as the flu will likely have mutated
during the year. The region where the best antibodies are to be found next
year will be slightly different from the region for this year. There may still
be a local minimum for the binding energy of next year’s flu to antibodies
around the best region for this year’s flu. If this is the case, that means
there is a barrier that separates the region of best antibodies from one year
to the next. This, in turn, means the immune system must overcome this
barrier in order to evolve the antibodies during the year. If, for example,
the individual dies from the flu before this barrier is overcome, this really is
localization of antibodies in sequence space. Note that the barrier may be
both energetic and entropic. That is, the mutations required to move from
one region to another may either lead to less favorable antibodies along the
9
0 10 20 30 40 50 60
Round
-20
-18
-16
-14
Be
st
 U
to
t
p=0.0
p=0.1
p=0.2
p=0.3
p=0.4
p=0.5
p=0.6
p=0.7
p=0.8
p=0.9
p=1.0
Primary and Secondary Immune Response
Figure 1: The dynamics of the immune response within the model. A
vaccine is given in the first year. The individual is exposed to the disease in
the second year. The disease differs from the vaccine by an amount p. The
results, as with all presented here, are averaged over 5000 ensembles.
way, or they may be more numerous than would be expected simply based
upon the amino acid differences between the two optimal regions
5 Original Antigenic Sin
Some specific results from the model clarify the concepts involved. In Fig.
1 is shown the dynamics of the immune response. Again, the starting point
is from 103 naive sequences. These sequences are evolved for 30 rounds. At
each round, the sequences are mutated at a rate of 0.5 mutations per sequence
per round, and the top 20% are kept. After the vaccination in year 1, the
person is exposed to the disease in year 2. The disease may be similar to or
very different from the vaccine. The degree of similarity is measured by the
parameter p. The secondary response starts with some naive sequences and
some memory sequences, weighted by the average binding constants and the
relative concentrations of each.
A key point about these results is that localization does occur. Shown in
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Figure 2: a) Comparison of primary and secondary response when the sec-
ondary response is from memory sequences only. b) Comparison when sec-
ondary response is shifted to the left to overlap with primary. c) Comparison
for a larger value of p.
2 is the behavior of the the primary and secondary response. In this figure
only, the secondary response is exclusively from memory sequences. It can be
seen that in the early part of the secondary response, the memory sequences
look superior to the naive sequences. By the end of 30 rounds, however,
the memory sequences are worse than the naive sequences due to an inferior
ability to evolve.
The results from 2 are somewhat academic, in that the true secondary
response was not used. In figure 3 is shown the response when the true
secondary response is used. It is again observed that the memory sequences
look promising at the beginning of the response, but they are unable to evolve
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Figure 3: a) Comparison of primary and secondary response when the sec-
ondary response is from memory and naive sequences. b) Comparison for a
larger value of p.
as well as naive sequences. In other words, the presence of the vaccine that
generated the memory response leads to a worse response than if there were
no vaccine. This is a demonstration of original antigenic sin.
It is of interest to measure the degree of original antigenic sin as a function
of the mutation of the flu. That is, one wants to compare the secondary
response at day 10 with a primary response at day 10. Shown in Fig. 4 is
this comparison. The secondary response is better than the primary when
the vaccine and flu are similar. When the vaccine and flu are very different,
the secondary response uses mostly naive sequences, and it becomes like a
primary response. In between, there is the region of original antigenic sin.
It is of interest to measure the degree of original antigenic sin as a func-
tion of the mutation of the flu. That is, Fig. 5 shows the evolved affinity
constant to a second antigen if the exposure to a first antigen exists (solid
line) or not (dashed line) as a function of the difference between the first
and second antigen, p, or “antigenic distance” (Smith et al., 1999). When
the difference is small, the exposure to a first antigen leads to higher affinity
constant than without exposure, which is why immune system memory and
vaccination is effective. For a large difference, the antigen encountered in the
first exposure is uncorrelated with that in the second exposure, and so im-
mune system memory does not play a role. Interestingly, the immunological
memory from the first exposure actually gives worse protection, i.e. a lower
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Figure 4: a) The model dynamics. The effectiveness of vaccination is deter-
mined by comparing the secondary response at round 60 with the primary
response at round 30. b) The energy evolved in the secondary response minus
that evolved in the primary response.
affinity constant, for intermediate differences—which is original antigenic sin.
The dynamics of the immune response (Fig. 4) depend upon the constants
of Nature, i.e. the parameters of the model. For example, in an organism
with a smaller immune system, such as the mouse, there are fewer starting
sequences, and less favorable binding constants are measured in the same
number of rounds: A factor of 0.5 reduction in the number of starting se-
quences leads to a 0.64 reduction in the evolved binding constant, but a
similar degree of original antigenic sin as in Fig. 4, as shown in Fig. 6. The
original antigenic sin curve looks very similar for the two repertoire sizes.
The only significant difference is that the absolute values of the evolved en-
ergies are slightly worse for the smaller repertoire size, due to the reduction
in diversity.
On the other hand, if more rounds are performed, better binding con-
stants are found in the primary and secondary responses, but the secondary
response is not as improved over the primary response as when using 30
rounds. This is because the evolved sequences are becoming more localized
in ever deeper wells. The degree of original antigenic sin is, however, simi-
lar in the range of 30 to 60 rounds per response. The model dynamics are
shown in Fig. 7. While 60 rounds is really too many for a single response,
13
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Figure 5: The evolved affinity constant to a second antigen after exposure
to an original antigen that differs by probability p (solid line). The dotted
line represents the affinity constant without previous exposure. The affinity
constant is generated by exponentiating, as in Eq. (6), the average of the
best binding energy.
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Figure 6: a) The model dynamics with a repertoire size of 500 instead
of 1000. The effectiveness of vaccination is determined by comparing the
secondary response at round 60 with the primary response at round 30. b)
The energy evolved in the secondary response minus that evolved in the
primary response.
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Figure 7: a) The model dynamics with 60 rounds instead of 30. The effec-
tiveness of vaccination is determined by comparing the secondary response
at round 120 with the primary response at round 60. b) The energy evolved
in the secondary response minus that evolved in the primary response.
this experiment could represent administration of a vaccine twice in year one,
administration of a vaccine once in year two, and exposure to the disease in
year two. In this case, one imagines that the two vaccines in year one are
identical and that the vaccine and disease in year two are identical.
Similarly, if the roughness of the energy upon disease mutation is in-
creased, for example by assuming that mutation of the influenza actually
changes the σα, the degree of original antigenic sin increases substantially,
by a factor of 2, because the barriers between the regions of localization in
sequence space are increased. On the other hand, if the concentration of
the memory cells is decreased, the contribution of the memory cells to the
dynamics is reduced, and the original antigenic sin phenomenon decreases,
almost disappearing when the memory and naive antibody concentrations
are equal. Larger selection strengths (x < 20%) cause more localization and
original antigenic sin, in shallower wells for small x, and smaller strengths
(x > 20%) lead to less evolution.
The average number of mutations leading to the best antibody, a measure
of the localization length when original antigenic sin occurs, is 15 for the
first response and rises from 5 to 15 for the second response in the range
0 ≤ p < 0.30, as shown in Fig. 8. Interestingly, the average number of
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Figure 8: The number of mutations that occur in the best evolved antibody
during the primary (dashed) and secondary (solid) responses.
mutations rises slightly above 15 in the range 0.30 ≤ p < 0.70, indicating
that in the original antigenic sin region more mutations are necessary for
the compressed ensemble of memory sequences from the primary response to
evolve to a suitable new state in the secondary response. This result implies
that there is at least some entropic character to the barrier between the
optimal regions of antibody sequence space from one year to the next.
For small values of p, p < 0.19, the memory B cells produce antibodies
with higher affinities, Keqm > 10
4 l/mol, for the new antigen than do naive
B cells. The binding constant of the memory antibodies steadily decreases
with p, reaching the non-specific value of Keqm = 10
2 at p = 0.36, as shown in
Fig. 9. Interestingly, this is less than the range to which original antigenic
sin extends, 0.23 < p < 0.60. These model predictions are in good agreement
with experimental data on cross-reactivity, which ceases to occur when the
amino acid sequences are more than 33–42% different (East et al., 1980).
This comparison also shows that the parameter p, which in the model is
the probability with which the parameters in the random energy model are
16
0 0.2 0.4 0.6 0.8 1p
100
102
104
106
K m
e
q
Memory B cell Affinity for Mutated Antigen
Figure 9: The affinity constant of an antibody as the antigen to which it
evolved against is mutated.
changed, can be interpreted as the degree of amino acid difference.
The ineffectiveness of immune system memory over a window of p values
can be understood from the localization of memory B cell sequences. Figure
10 displays distributions of memory and naive affinity constants for the sec-
ond antigen. Notice that the memory sequences are highly homogeneous and
lack diversity compared to the naive sequences. Indeed, original antigenic sin
arises mainly because the memory sequences from the primary response sup-
press use of naive sequences in the tail of the distribution for the secondary
response. Although those naive sequences initially look unpromising, they
may actually evolve to sequences with superior binding constants. Figure
11 illustrates this phenomenon. Interestingly, when half of the distribution
is removed, the reduction in the binding constant is just about that which
occurs in original antigenic sin, Fig. 5.
The phenomenon of original antigenic sin, then, arises because the mem-
ory sequences cut off the tail of the naive sequences with poor binding con-
stants. In most cases, i.e. for most values of p, this is an appropriate strategy.
In some cases, however, those unpromising looking sequences actually lead to
a better evolved binding constant than do the memory sequences. It is these
cases in which original antigenic sin occurs. This mechanism can be tested
by allowing evolution of only the top fraction of naive sequences. That is, the
top fraction of the sequences is kept, overwriting the bottom fraction with
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Figure 10: The affinity distribution of antibodies from naive B cells (hatched)
or memory cells (open) for the antigen of second exposure.
the worst kept sequence. The repertoire size is still 103, but the diversity is
the fraction kept times 103. Shown in Fig. 11 is the result. It is seen that if
only the best sequences is kept, a very poor evolved antibody results. If only
the 50% best sequences are kept, the best evolved antibody is worse by just
about the depth of the original antigenic sin valley in Fig. 5.
6 Single and Repeated Vaccination
The model is also used to address the effectiveness of repeated annual
influenza vaccination. Repeated vaccination will lead to a more effective
response against closely related antigens. The ratio of the affinity constant
to influenza after repeated vaccination, Keqr , to that after single vaccination,
Keqs , should be greater than unity for small p and converge to unity for p→
1. Repeated vaccination generates highly localized memory cells that have
higher affinity constants to both the vaccine and the influenza if p is small.
Results for our model are shown in Figs. 12 and 13. The decay of the ratio
Keqr /K
eq
s to unity is in accord with experimental data (Smith et al., 1999).
Interestingly, for our present vaccination protocol, no localization is observed,
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Figure 11: The evolved binding constant when only the top fraction of naive
sequences are kept in the dynamics.
which is consistent with most of the modern experiments and with current
public health policy that recommends for repeated, annual vaccinations of
individuals at risk.
7 Summary
In summary, the generalized NK model is shown to successfully model im-
mune system dynamics. A localization mechanism for the original antigenic
sin phenomenon observed in the flu is explained. Localization of antibodies
in the amino acid sequence space around memory B cell sequences is shown
to lead to a decreased ability of the immune system to respond to diseases
with year-to-year mutation rates within a critical window. This localization
occurs because of the ruggedness of the evolved affinity constant in amino
acid sequence space.
From the model dynamics, it is found that memory sequences can both
out compete the non-vaccinated immune response and become trapped in
local minima. Memory sequences with affinity constants initially superior to
those from naive sequences can be selected by the dynamics, and these mem-
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Figure 12: a) Dynamics with single vaccination. b) Dynamics with repeated
vaccination. c) Comparison between single and repeated vaccination.
20
0 0.2 0.4 0.6 0.8 1p
0
1
2
3
K r
e
q 
 
/ K
se
q
Figure 13: The ratio of the affinity constants to influenza after repeated
vaccination and single vaccination.
ory sequences can lead to poorer evolved affinity constants, to the detriment
of the immune system for intermediate disease mutation rates. Interestingly,
due to the high diversity of the naive sequences, the localization phenomenon
extends even beyond the region of cross-reactivity between memory antibod-
ies and mutated antigen.
These results suggest several implications for vaccination strategy: the
difference between vaccinations administered on a repeated basis should be
as great as practicable, and suppression of the memory B cell response may
be helpful during vaccination against highly variable antigens.
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